Welcome to NHS Blood and Transplant's Review of
2010/11. We hope it gives you an insight into the ways
we are saving and improving patients' lives.
We are proud of the many successes we achieved in 2010/11
due mainly to the professionalism and expertise of our
staff. We are even more grateful to the thousands of
ordinary people who do something extraordinary and make
a life-saving and entirely altruistic donation to help
someone else often a complete stranger. Without them,
we could not continue towards our goal of delivering a
world-class service to the NHS.
"NHSBT has done a great job and it continues
to do so. It has greatly improved the stability and
security of the blood supply and also improved
productivity in blood processing and testing ...
which is a true achievement."
Anne
Milton, Public Health Minister (June 2011)
In 2010/11 we
progressed well against our key objectives, which were
to:
- Provide an efficient, sustainable and
dependable supply of blood components that meet all
safety, quality, compliance and service standards
- Provide a range of specialist services and advice
to hospitals
- Maximise the number of organ
donors, donated organs and registered supporters of
organ donation, thereby enabling an increase in the
number of life-saving transplants
- Ensure NHS
Blood and Transplant is an effective, responsive
organisation, focused on the changing needs of donors,
hospitals and other customers.
In July 2010 the new Coalition Government published the
outcome of the
Arm's-Length Bodies review confirming our
continued status as a Special Health Authority and
acknowledging our unique contribution to the NHS.
At the same time, the review said there may be
opportunities for more cost effective operations and
commercial arrangements - this is the subject of a
separate review due for completion in autumn 2011.
The Arm's-Length Bodies review also announced the
transfer of the Bio Products Laboratory (BPL) from NHSBT
to new management arrangements which was completed in
January 2011. This was the right move for BPL staff,
customers and the Department of Health as it allows Bio
Products Laboratory Ltd to take advantage of a broader
range of growth and development opportunities.
Looking ahead to 2011/12, the Government's plans to
reform the NHS will see power and funding devolved from
Whitehall to patients and professionals. We are well
placed to take advantage of the opportunities this
presents for improving our services to the front line of
care to patients.
Our Strategic Plan for 2011/14 builds on the improvements of recent years but
also contains a commitment to deliver challenging new
initiatives. Safety and sufficiency will remain the
bedrock of all that we do. In addition, a continued
focus on efficiency and both donor and customer
satisfaction will help us achieve our vision to be the
best organisation of our type in the world and ensure
more patients' lives are saved.
Click here to view
Our Achievements.
Lynda Hamlyn, Chief Executive
Bill Fullagar, Chairman